These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 9777006)
21. Determination and pharmacokinetic study of taxifolin in rabbit plasma by high-performance liquid chromatography. Pozharitskaya ON; Karlina MV; Shikov AN; Kosman VM; Makarova MN; Makarov VG Phytomedicine; 2009 Mar; 16(2-3):244-51. PubMed ID: 19110406 [TBL] [Abstract][Full Text] [Related]
22. Mefenamic acid bioequivalence assessment with a new statistical procedure. Rescigno A; Marzo A; Thyroff-Friesinger U Pharmacol Res; 1996; 34(3-4):149-52. PubMed ID: 9051707 [TBL] [Abstract][Full Text] [Related]
23. The anti-diabetic effects and pharmacokinetic profiles of bis(maltolato)oxovanadium in non-diabetic and diabetic rats. Zhang SQ; Zhong XY; Chen GH; Lu WL; Zhang Q J Pharm Pharmacol; 2008 Jan; 60(1):99-105. PubMed ID: 18088510 [TBL] [Abstract][Full Text] [Related]
24. Glucuronidation of fenamates: kinetic studies using human kidney cortical microsomes and recombinant UDP-glucuronosyltransferase (UGT) 1A9 and 2B7. Gaganis P; Miners JO; Knights KM Biochem Pharmacol; 2007 May; 73(10):1683-91. PubMed ID: 17343829 [TBL] [Abstract][Full Text] [Related]
25. [Biopharmaceutical evaluation of the intrarectal use of mefenamic acid. III. Effect of solubilizers on the biological availability of mefenamic acid from witepsol H15]. Kosior A Acta Pol Pharm; 1986; 43(2):156-60. PubMed ID: 3776655 [No Abstract] [Full Text] [Related]
26. Some physicochemical properties of mefenamic acid. Adam A; Schrimpl L; Schmidt PC Drug Dev Ind Pharm; 2000 May; 26(5):477-87. PubMed ID: 10789059 [TBL] [Abstract][Full Text] [Related]
27. Mefenamic acid bi-directionally modulates the transient outward K+ current in rat cerebellar granule cells. Zhang M; Shi WJ; Fei XW; Liu YR; Zeng XM; Mei YA Toxicol Appl Pharmacol; 2008 Feb; 226(3):225-35. PubMed ID: 17961620 [TBL] [Abstract][Full Text] [Related]
28. Mefenamic acid shows neuroprotective effects and improves cognitive impairment in in vitro and in vivo Alzheimer's disease models. Joo Y; Kim HS; Woo RS; Park CH; Shin KY; Lee JP; Chang KA; Kim S; Suh YH Mol Pharmacol; 2006 Jan; 69(1):76-84. PubMed ID: 16223958 [TBL] [Abstract][Full Text] [Related]
29. Possible antidiabetic and antihyperlipidaemic effect of fermented Parkia biglobosa (JACQ) extract in alloxan-induced diabetic rats. Odetola AA; Akinloye O; Egunjobi C; Adekunle WA; Ayoola AO Clin Exp Pharmacol Physiol; 2006 Sep; 33(9):808-12. PubMed ID: 16922811 [TBL] [Abstract][Full Text] [Related]
31. Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts. Reid PC; Virtanen-Kari S BJOG; 2005 Aug; 112(8):1121-5. PubMed ID: 16045528 [TBL] [Abstract][Full Text] [Related]
32. Comparison of the effectiveness of fennel and mefenamic acid on pain intensity in dysmenorrhoea. Modaress Nejad V; Asadipour M East Mediterr Health J; 2006; 12(3-4):423-7. PubMed ID: 17037712 [TBL] [Abstract][Full Text] [Related]
33. Synthesis, Biological Evaluation and Pharmacokinetic Studies of Mefenamic Acid - N-Hydroxymethylsuccinimide Ester Prodrug as Safer NSAID. Husain A; Ahuja P; Ahmad A; Khan SA Med Chem; 2016; 12(6):585-91. PubMed ID: 26740206 [TBL] [Abstract][Full Text] [Related]
34. Effect of mefenamic acid on controlling irregular uterine bleeding in DMPA users. Tantiwattanakul P; Taneepanichskul S Contraception; 2004 Oct; 70(4):277-9. PubMed ID: 15451330 [TBL] [Abstract][Full Text] [Related]
35. Environmental photodegradation of mefenamic acid. Werner JJ; McNeill K; Arnold WA Chemosphere; 2005 Mar; 58(10):1339-46. PubMed ID: 15686751 [TBL] [Abstract][Full Text] [Related]
36. Skin penetration enhancement of mefenamic acid by ethanol and 1,8-cineole can be explained by the 'pull' effect. Heard CM; Kung D; Thomas CP Int J Pharm; 2006 Sep; 321(1-2):167-70. PubMed ID: 16787720 [TBL] [Abstract][Full Text] [Related]
37. The effects of mefenamic acid on the osmotic fragility of lacertilian erythrocytes. Ahmad M; Hasan R; Qureshi A; Ahmad M; Ahmed Z Pak J Pharm Sci; 2005 Apr; 18(2):14-8. PubMed ID: 16431392 [TBL] [Abstract][Full Text] [Related]
38. Effect of zinc on the lipid peroxidation and the antioxidant defense systems of the alloxan-induced diabetic rabbits. Duzguner V; Kaya S Free Radic Biol Med; 2007 May; 42(10):1481-6. PubMed ID: 17448894 [TBL] [Abstract][Full Text] [Related]
39. Serum sialic acid concentration and glycoprotein sialosylation in relation to temporary development of experimental alloxan induced diabetes in rabbits. Kozioł-Montewka M; Wójtowicz Z; Ksiazek A; Grzebalska A; Ksiazek P; Sidor-Wójtowicz A; Donica H; Spasiewicz D Ann Univ Mariae Curie Sklodowska Med; 1999; 54():331-5. PubMed ID: 11205786 [No Abstract] [Full Text] [Related]
40. [Study on the pharmacokinetics and bioavailability of syringic acid in rabbits]. Liu Y; Guo X; Lü Z; Xie W Zhong Yao Cai; 2003 Nov; 26(11):798-801. PubMed ID: 14989061 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]